An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of Oral Harnalidge® OCAS® (Tamsulosin) 0.4 mg in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2 mg

Hou C1, Yang P1, Hou C1, Lin Y1, Chang P1, Tsui K1

Research Type

Clinical

Abstract Category

Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Abstract 829
Non Discussion Abstracts
Scientific Non Discussion Abstract Session 32
Benign Prostatic Hyperplasia (BPH) Bladder Outlet Obstruction Clinical Trial Pharmacology Prospective Study
1. Chang Gung Memorial Hospital, Linkou Medical Center
Links

Abstract

19/04/2024 03:10:55